RLX Technology Inc. research snapshot
RLX AI stock analysis reads RLX Technology Inc. as a cash-rich Chinese e-vapor company whose international pivot is now the dominant revenue engine. At the August 4, 2026 data cutoff, RLX closed near $1.99 on August 3, 2026, with a market capitalization of about $2.43 billion verified against 1.23 billion ADS-equivalent shares, and trailing GAAP EPS of about $0.11. Q1 2026 net revenues grew 96.2% year over year to RMB 1,585.8 million ($229.9 million), with international business at 72.3% of revenue and gross margin at 31.8%. The company holds roughly $2.1 billion in total liquid assets, so the operating business carries a low enterprise value. This page uses scenario ranges, not a certain stock price prediction, and it is an informational tool rather than investment advice.
Current price
$1.99
Market cap
$2.43 billion
AI score
58 / 100
Rating
Cash-rich Chinese e-vapor company accelerating international expansion with strong revenue growth and persistent regulatory risk
Trend status
Above the 50-day average near $1.98 but below the 200-day average near $2.22
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | RLX Technology sells branded e-vapor products (RELX) in China and internationally. Q1 2026 net revenues grew 96.2% year over year to RMB 1,585.8 million, driven by international expansion, the May 2025 European acquisition, a stronger mainland China business, and a one-time benefit from China export policy changes. | Medium |
| Moat | The moat is moderate and improving internationally through brand, distribution partnerships, regulatory compliance capability, and the integrated Nexus manufacturing hub. Switching costs are low in e-vapor, and regulatory barriers can help or hurt incumbents depending on enforcement direction. | Low-medium |
| Management | Founder and CEO Kate Wang and CFO Chao Lu steered the business through severe Chinese regulatory headwinds after 2021, pivoted to international markets, maintained a fortress balance sheet, and returned over $500 million cumulatively through buybacks and dividends. The share repurchase program was extended through December 31, 2027. | Medium |
| Financial trend | FY2025 net revenues grew 44.0% to RMB 3,958.9 million, GAAP net income grew 65.6% to RMB 934.4 million, and gross margin improved to 29.9% from 26.4%. Q1 2026 continued the momentum with 96.2% revenue growth and gross margin of 31.8%, up from 28.6% a year earlier. | High |
| Valuation | At $1.99 and about $0.11 trailing EPS, the verified trailing P/E is roughly 18x. The stock trades modestly above net cash per share of about $1.10, implying the operating business is valued at a low EV of about $1.09 billion, and the trailing dividend yield is 5.53%. | High for math, low for regulatory visibility |
| Technical trend | RLX trades just above its 50-day moving average near $1.98 but below the 200-day average near $2.22, and sits well below the $2.84 52-week high. The stock has moved off its $1.76 52-week low and shows a neutral RSI near 50, suggesting a basing phase rather than a confirmed breakout. | Low-medium |
| Risk level | Risk is high. Chinese e-vapor regulation, potential US FDA enforcement, competitive pressure in Europe and Asia, foreign ownership rules for Chinese ADRs, a near-100% dividend payout ratio, and US-China geopolitical tension all create material downside scenarios. | Medium-high |
| AI confidence | Medium-high confidence for reported financials, market-cap math, cash position, and valuation math. Lower confidence for regulatory trajectory, durability of international growth, and whether the recent revenue acceleration persists without one-time tailwinds. | Medium-high data confidence |
| Investment certainty | Medium-low certainty. The balance sheet provides a floor and the payout supports income, but the operating business still faces structural regulatory and competitive risks that are difficult to model with confidence. | Low-medium |
RLX AI stock forecast
The RLX AI stock forecast uses scenario ranges around the $1.99 quote and a two-year EPS growth and multiple model. The bullish case assumes sustained international growth and margin expansion, the base case assumes moderation in international growth, and the bearish case assumes regulatory or competitive setbacks.
$3.50 to $5.50
More likely if international revenue keeps growing at 30% or more annually, gross margin expands above 32%, mainland China stabilizes or recovers, buybacks continue, and the market re-rates the stock toward 25x forward earnings on a durable EPS trajectory. A two-year model at 30% growth and a 25x multiple supports the upper end of this range.
$2.10 to $3.00
More likely if international growth moderates to a 15% to 20% range, China stays flat to slightly recovering, gross margin holds near 30%, and the stock trades at an 18x to 20x forward multiple. A two-year model at 15% growth and an 18x multiple gives about $2.60.
$1.10 to $1.80
More likely if Chinese regulatory pressure intensifies, international expansion hits competitive or regulatory headwinds, US-China tensions affect ADR access, gross margin contracts from aggressive pricing, or the dividend is cut given the near-100% payout ratio.
RLX AI technical analysis
RLX AI technical analysis starts from the $1.99 close on August 3, 2026 near the August 4, 2026 cutoff, the $1.76 to $2.84 52-week range, and the 50-day and 200-day moving averages near $1.98 and $2.22. Because this static page does not fetch request-time chart data, live price, volume, RSI, and moving averages should be confirmed before trading.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $1.99 | Closing quote on August 3, 2026, used for this page near the August 4, 2026 data cutoff. |
| Near support | $1.90 to $1.98 | The 50-day moving average near $1.98 and the recent day range provide the nearest support. A loss of this zone would test the 52-week low. |
| Deeper support | $1.76 to $1.85 | The $1.76 52-week low is the main downside reference. A break below it would open lower price territory with no recent tape to lean on. |
| Near resistance | $2.04 to $2.15 | Recent intraday highs near $2.04 and the $2.10 to $2.15 zone act as initial resistance before the longer-term averages. |
| Key resistance | $2.22 to $2.84 | The 200-day moving average near $2.22 is the first structural hurdle, with the 52-week high of $2.84 as the upper reference. A decisive break above $2.22 with volume would signal a stronger trend change. |
| Moving averages | 50-day near $1.98, 200-day near $2.22 | Price is just above the 50-day average and below the 200-day average, a mixed picture that needs a daily close above $2.22 to turn structurally bullish. |
| Momentum | RSI near 49.75 | Relative strength near the midpoint is neutral. RSI trending above 50 with higher price closes would confirm momentum turning up. |
| Volume | 1,471,874 on August 3, 2026 vs 20-day average near 1,786,087 | Recent volume is below the 20-day average, suggesting consolidation. A volume spike on a break above $2.22 would add confidence. |
| Volatility | Moderate, beta 1.15 | Beta of 1.15 indicates slightly higher volatility than the broad market, typical for a small-cap Chinese ADR. |
| Invalidation | Close below $1.76 | A decisive close below the 52-week low would invalidate the basing setup and suggest further downside risk. |
RLX AI trading strategy
The RLX AI trading strategy is a rules-based framework for a Chinese ADR e-vapor company in transition. It is not personalized advice. Any setup should be paired with position sizing, stop levels, updated filings, and live chart confirmation.
Wait for RLX to hold above the $1.98 zone and reclaim the 200-day average near $2.22 with improving volume. Monitor international revenue growth, gross margin, and regulatory news from China and Europe as fundamental confirmation.
A failed break above resistance or a close back below the 50-day average should invalidate the setup. Position size should reflect the high regulatory uncertainty and the near-100% dividend payout ratio.
At a trailing P/E near 18x, a 5.53% dividend yield, and net cash near $1.10 per share, RLX offers an income plus asset value profile. Compare the EV of about $1.09 billion with international e-vapor peers and track dividend sustainability given the payout ratio.
Do not treat net cash or the dividend as a guaranteed floor. Chinese ADR structural risks, including potential delisting or capital controls, can erode both. Monitor cash flow and payout coverage each quarter.
Track international revenue share, gross margin trajectory, quarterly cash flow, Chinese regulatory announcements, European market expansion, the pending August 21, 2026 earnings report, competitors (Smoore, British American Tobacco, Juul), and US-China ADR policy.
Reduce confidence if international revenue growth decelerates for two consecutive quarters, gross margin declines, the dividend is cut, or regulatory headwinds in key markets intensify.
Investment research summary
Customers buy RLX e-vapor products as an alternative to traditional cigarettes. Revenue comes from device sales and consumable pods and cartridges, with international business now the majority at 72.3% of Q1 2026 net revenues.
RLX has a moderate and growing moat through its RELX brand, regulatory compliance infrastructure, the integrated Nexus manufacturing and R&D hub, and distribution partnerships in Europe and Asia. Switching costs stay low in vaping, and well-funded global tobacco companies are strong competitors.
The thesis can fail if Chinese regulators reimpose severe restrictions, if US-China tensions lead to ADR delisting, if international expansion costs outpace revenue, if global competitors outspend RLX on marketing and distribution, if the near-100% payout forces a dividend cut, or if public health concerns drive blanket vaping bans in key markets.
CEO Kate Wang co-founded the company in 2018 and led the pivot from China to global markets after the 2021 to 2022 regulatory crackdown. Management has returned over $500 million via buybacks and dividends, executed a European acquisition in May 2025, and extended the share repurchase program through December 31, 2027.
The global e-vapor market is growing as harm-reduction products gain acceptance and traditional smoking declines, while regulatory frameworks mature. Europe offers near-term growth, mainland China is recovering for compliant players, and developing Asia adds a long-term option. The industry still faces constant regulatory, health, and public perception risk.
A verified trailing P/E near 18x, a market cap of about $2.43 billion, an EV of about $1.09 billion, and roughly $2.1 billion in total liquid assets mean the enterprise is priced at a low absolute multiple with a 5.53% dividend yield. The balance sheet and payout provide some downside cushion, but regulatory and execution risk keep the cash-adjusted view less certain for a Chinese ADR.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| RLX price | $1.99 close on August 3, 2026 | StockAnalysis.com RLX quote | August 4, 2026 |
| Market capitalization | $2.43 billion reported, verified as $1.99 x 1,232,448,894 shares (deviation 0.93%) | financial_rigor.py market cap verification and StockAnalysis.com | August 4, 2026 |
| Share count | 1,232,448,894 basic ADS-equivalent shares as of Q1 2026 | RLX Q1 2026 earnings release | August 4, 2026 |
| Q1 2026 net revenues | RMB 1,585.8 million ($229.9 million), up 96.2% year over year | RLX Q1 2026 earnings release | August 4, 2026 |
| Q1 2026 gross margin | 31.8%, up from 28.6% a year earlier | RLX Q1 2026 earnings release | August 4, 2026 |
| Q1 2026 GAAP net income | RMB 294.2 million ($42.6 million), up 32.1% year over year | RLX Q1 2026 earnings release | August 4, 2026 |
| International revenue share | 72.3% of Q1 2026 net revenues | RLX Q1 2026 earnings release | August 4, 2026 |
| FY2025 net revenues | RMB 3,958.9 million ($566.1 million), up 44.0% | RLX FY2025 earnings release | August 4, 2026 |
| FY2025 GAAP net income | RMB 934.4 million ($133.6 million), up 65.6% | RLX FY2025 earnings release | August 4, 2026 |
| Total liquid assets | RMB 14,529.7 million ($2,106.4 million) as of March 31, 2026 | RLX Q1 2026 balance sheet | August 4, 2026 |
| Valuation math | Trailing P/E near 18x, forward P/E 13.19, P/B 1.07, EV about $1.09 billion, dividend yield 5.53% | financial_rigor.py and StockAnalysis.com statistics | August 4, 2026 |
| Net cash | About $1.35 billion, or roughly $1.10 per share | StockAnalysis.com statistics | August 4, 2026 |
| Cumulative shareholder returns | $330 million in buybacks and about $171 million in dividends as of March 2026 | RLX FY2025 earnings release | August 4, 2026 |
| Analyst view | Consensus Strong Buy from 5 analysts, average price target $2.95 (Citi at $2.50 with a Neutral rating) | StockAnalysis.com forecast | August 4, 2026 |
| Technical range | 52-week range $1.76 to $2.84; 50-day average near $1.98; 200-day average near $2.22 | StockAnalysis.com statistics | August 4, 2026 |
This RLX AI stock analysis page is an informational research tool only. It is not investment advice, a recommendation, or a promise of future performance. Forecast ranges are scenarios based on available data as of August 4, 2026 and can be wrong if fundamentals, price action, filings, regulatory environment, payout policy, or market conditions change.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
